SIG
Stonegate Investment Group’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.43M | Buy |
40,031
+1,790
| +5% | +$332K | 0.19% | 59 |
|
|
2025
Q1 | $8.01M | Buy |
38,241
+588
| +2% | +$123K | 0.21% | 55 |
|
|
2024
Q4 | $6.69M | Buy |
37,653
+3,996
| +12% | +$710K | 0.18% | 60 |
|
|
2024
Q3 | $6.65M | Buy |
33,657
+857
| +3% | +$169K | 0.18% | 60 |
|
|
2024
Q2 | $5.63M | Buy |
32,800
+1,682
| +5% | +$288K | 0.16% | 61 |
|
|
2024
Q1 | $5.67M | Sell |
31,118
-358,321
| -92% | -$65.3M | 0.18% | 67 |
|
|
2023
Q4 | $60.4M | Buy |
389,439
+22
| +0% | +$3.41K | 2% | 16 |
|
|
2023
Q3 | $58M | Sell |
389,417
-209
| -0.1% | -$31.2K | 2.11% | 17 |
|
|
2023
Q2 | $52.5M | Buy |
389,626
+648
| +0.2% | +$87.3K | 1.87% | 17 |
|
|
2023
Q1 | $62M | Buy |
388,978
+10,718
| +3% | +$1.71M | 2.33% | 14 |
|
|
2022
Q4 | $61.1M | Sell |
378,260
-808
| -0.2% | -$131K | 2.64% | 13 |
|
|
2022
Q3 | $50.9M | Buy |
379,068
+2,300
| +0.6% | +$309K | 2.33% | 14 |
|
|
2022
Q2 | $57.7M | Buy |
376,768
+10,815
| +3% | +$1.66M | 2.53% | 11 |
|
|
2022
Q1 | $59.3M | Buy |
365,953
+7,973
| +2% | +$1.29M | 1.95% | 14 |
|
|
2021
Q4 | $48.5M | Buy |
+357,980
| New | +$48.5M | 2.03% | 13 |
|